Name: Anbio Biotechnology (NNNN) Balance Sheet
Creator: FinSpry

Anbio Biotechnology Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Anbio Biotechnology (NNNN) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Current Assets
Cash and Cash Equivalents	11.76	9.69	7.10	4.18
Short-Term Investments	0.00	0.00	1.57	0.00
Cash & Short-Term Investments	11.76	9.69	8.67	4.18
Accounts Receivable	1.06	1.88	0.00	0.72
Inventory	0.00	0.00	0.35	0.00
Other Current Assets	5.71	4.17	4.92	0.02
Total Current Assets	18.53	15.75	13.94	4.92
Non-Current Assets
Property, Plant & Equipment (Net)	0.00	0.00	0.01	0.00
Other Non-Current Assets	0.39	0.02	0.00	0.00
Total Non-Current Assets	0.39	0.06	0.02	0.00
Total Assets	18.92	15.81	13.96	4.92
Current Liabilities
Accounts Payable	1.63	0.83	1.41	1.89
Accrued Liabilities	0.00	0.13	0.00	0.00
Deferred Revenue	0.00	0.00	0.00	0.49
Other Current Liabilities	0.10	0.03	0.00	0.49
Total Current Liabilities	1.73	0.99	1.41	2.38
Non-Current Liabilities
Long-Term Debt	0.00	0.00	0.00	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	0.00	0.00	0.00	0.00
Total Liabilities	1.73	0.99	1.41	2.38
Stockholders' Equity
Common Stock	0.01	0.01	0.00	0.00
Retained Earnings	17.17	14.80	12.55	2.54
Additional Paid-in Capital	0.00	0.00	0.00	0.00
Shares Outstanding	43.89	43.89	43.89	43.89
Total Stockholders' Equity	17.19	14.82	12.55	2.54
Total Liabilities & Equity	18.92	15.81	13.96	4.92